Pharma firm Corona Remedies, backed by ChrysCapital, has set its IPO price band at Rs 1,008-1,062, valuing the company at nearly Rs 6,500 crore. The Rs 655.37 crore public offering, an Offer For Sale, opens December 8 and closes December 10. The company, a leader in women’s healthcare and cardio-diabeto segments, aims to debut on December 15.